Rxsight Inc reports results for the quarter ended in June - Earnings Summary

RxSight

05/08/2024 22:01

* Rxsight Inc  RXST.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -39
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 22 cents per share. Wall Street expected
results to range from -24 cents to -20 cents per share.
    * Revenue rose 67.6% to $34.89 million from a year ago;
analysts
expected $32.28 million. 
    * Rxsight Inc's reported EPS for the quarter was a loss
of 16
cents​.
    * The company reported a quarterly loss of $6.08 million.
    * Rxsight Inc shares had fallen by 30.6% this quarter and
gained 3.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is  "buy."

Wall Street's median 12-month price target for Rxsight Inc is
$72.00 
This summary was machine generated from LSEG data August 5 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.22          -0.16          Beat
 Mar. 31 2024      -0.27          -0.25          Beat
 Dec. 31 2023      -0.36          -0.26          Beat
 Sep. 30 2023      -0.43          -0.31          Beat